Sickle Cell Disease Expanded Access Program

People with sickle cell disease are asked to participate in an expanded access program being conducted by Queens Hospital Center. This program is for patients with Sickle Cell Disease who have no other treatment options and would allow you access to a drug that is not yet commercially available.

You/your child may be eligible to participate in this study if you or your child:

  • Are a male or female at least 12 years of age older
  • Have documented diagnosis of sickle cell disease of any genotype

You/your child may not participate in this study if you/your child:

  • Have participated in another clinical trial of an investigational agent (or medical device) within the past 30 days
  • Have known immunodeficiency virus (HIV) infection, hepatitis B or hepatitis C
  • Are pregnant or breastfeeding

Contact Information

Linda Bulone, Study Coordinator
82-68 164th St. A-541, New Building, 5th Floor
Jamaica, NY 11432
Phone: (718) 883-3751


19-10-242 / TX228677